Prognostic value of tumor size varies by treatment in a meta-analysis of 15 randomized clinical trials in advanced non-small cell lung cancer across immunotherapy, TKI, and chemotherapy regimens

This work was recently presented as a poster at the SITC 2020 (Immuno-oncology conference) and @jackinovik wrote up a nice summary on our blog. We (Jacki, @sambrilleman, @sakrejda, @syclik) worked on it for over two years and there is no way we could have done it without Stan.